Stay updated on COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Sign up to get notified when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.
Latest website image capture
Clouds background image

Latest updates to the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page history shows a minor revision update (v3.3.2) replacing v3.3.1, a footer-level change with no impact on core content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T17:24:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The history shows an addition of Revision: v3.3.1 and a deletion of Revision: v3.2.0, indicating a routine site update with no impact on trial data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T13:51:44.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The top banner informing users about government funding and potential delays was removed. The page now shows the record history without that informational notice.
    Difference
    0.2%
    Check dated 2025-11-17T06:27:23.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page history introduces a Recruitment Status entry in the navigation, and subsequent versions show updates to Study Status and related sections.
    Difference
    0.1%
    Check dated 2025-11-03T01:08:25.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    7%
    Check dated 2025-10-05T09:09:05.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.
    Difference
    0.2%
    Check dated 2025-09-28T03:04:00.000Z thumbnail image

Stay in the know with updates to COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma

Enter your email address, and we'll notify you when there's something new on the COMBI-AD Trial: Dabrafenib + Trametinib in Melanoma page.